Peptide discovery firm using AI to find Covid-19 drug
‘Covid-19 and the various viral mutations will likely be with us for a long time and thus effective treatment is key,’ says Pepticom CEO.
‘Covid-19 and the various viral mutations will likely be with us for a long time and thus effective treatment is key,’ says Pepticom CEO.
‘Instead of having to check millions of molecules, we may check just 20, 100 or maybe up to 3,000 molecules,’ says Jerusalem-based Pepticom.
Amazing new technologies for beating conditions including breast cancer, ALS and obesity are under development in Israel’s capital city.